Atorvastatin-Loaded Mineralized Vaccine Reprograms Endosomal Trafficking to Amplify STING-Driven Cancer Immunotherapy
Yuhan Yang
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Both authors contributed equally to this work.
Search for more papers by this authorWei Long
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Both authors contributed equally to this work.
Search for more papers by this authorXiangyu Pei
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorShangfei Li
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorBowen Fu
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorHao Zhai
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorXiaoyi Zhang
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorYing Wan
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorCorresponding Author
Prof. Yayun Peng
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
E-mail: [email protected]; [email protected]
Search for more papers by this authorCorresponding Author
Ting Cai
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
E-mail: [email protected]; [email protected]
Search for more papers by this authorYuhan Yang
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Both authors contributed equally to this work.
Search for more papers by this authorWei Long
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Both authors contributed equally to this work.
Search for more papers by this authorXiangyu Pei
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorShangfei Li
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorBowen Fu
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorHao Zhai
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorXiaoyi Zhang
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorYing Wan
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
Search for more papers by this authorCorresponding Author
Prof. Yayun Peng
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
E-mail: [email protected]; [email protected]
Search for more papers by this authorCorresponding Author
Ting Cai
Department of Pharmaceutics, School of Pharmacy, Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198 P.R. China
E-mail: [email protected]; [email protected]
Search for more papers by this authorGraphical Abstract
A biomineralized nanovaccine (OVA-ATV@MnO₂) spatiotemporally co-delivers and releases tumor antigen, atorvastatin, and Mn adjuvants in dendritic cells. Atorvastatin reprograms endosomal trafficking to delay lysosomal degradation, enhancing antigen cross-presentation via MHC-I, while Mn2+ activates the cGAS-STING pathway, amplifying dendritic cell maturation and antitumor T-cell responses. This dual-action strategy achieves potent tumor regression, suppresses metastasis, and establishes durable anticancer immunity.
Abstract
Dendritic cell (DC)-targeted nanovaccines offer great promise for cancer immunotherapy but are severely limited by premature lysosomal degradation of antigens, which reduces cross-presentation efficacy. Here, we report a facile yet effective biomineralization strategy to construct nanovaccine (OVA-ATV@MnO₂) that co-delivers ovalbumin (OVA) and atorvastatin (ATV) within MnO₂ matrix. The ATV-mediated nanovaccine reprograms endosomal trafficking by inhibiting the mevalonate (MVA) pathway, thereby delaying endosomal maturation and preventing antigen diversion to degradative lysosomes. This intervention significantly enhances antigen preservation and MHC-I presentation in DCs. Simultaneously, the MnO₂ framework not only stabilizes the vaccine nanostructure but also releases Mn2⁺ ions as an adjuvant to potently activate the cGAS-STING pathway, amplifying DC maturation and antitumor T-cell priming. In vivo studies demonstrate that the nanovaccine induces robust tumor regression, suppresses metastasis, and establishes durable prophylactic immunity. By synergistically rewiring intracellular antigen trafficking and amplifying STING-mediated immune activation, this mineralized vaccine platform provides a transformative strategy for precise cancer immunotherapy.
Conflict of Interests
The authors declare no conflict of interest.
Open Research
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Supporting Information
Filename | Description |
---|---|
anie202503749-sup-0001-SuppMat.pdf9.4 MB | Supporting Information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1I. Mellman, G. Coukos, G. Dranoff, Nature 2011, 480, 480–489.
- 2J. Nam, S. Son, K. S. Park, W. Zou, L. D. Shea, J. J. Moon, Nat. Rev. Mater. 2019, 4, 398–414.
- 3W. Jiang, Y. Wang, J. A. Wargo, F. F. Lang, B. Y. S. Kim, Nat. Nanotechnol. 2021, 16, 6–15.
- 4Y. Yang, Y. Yu, H. Chen, X. Meng, W. Ma, M. Yu, Z. Li, C. Li, H. Liu, X. Zhang, H. Xiao, Z. Yu, ACS Nano 2020, 14, 13536–13547.
- 5L. Yu, Z. Wang, Z. Mo, B. Zou, Y. Yang, R. Sun, W. Ma, M. Yu, S. Zhang, Z. Yu, Acta Pharm. Sin. B 2021, 11, 2004–2015.
- 6X. Tan, J. Huang, Y. Wang, S. He, L. Jia, Y. Zhu, K. Pu, Y. Zhang, X. Yang, Angew. Chem. Int. Ed. 2021, 60, 14051–14059.
- 7S. Peng, A. Lin, A. Jiang, C. Zhang, J. Zhang, Q. Cheng, P. Luo, Y. Bai, Mol. Cancer 2024, 23, 58.
- 8S. H. van der Burg, R. Arens, F. Ossendorp, T. van Hall, C. J. Melief, Nat. Rev. Cancer 2016, 16, 219–233.
- 9M. Saxena, S. H. van der Burg, C. J. M. Melief, N. Bhardwaj, Nat. Rev. Cancer 2021, 21, 360–378.
- 10Z. Hu, P. A. Ott, C. J. Wu, Nat. Rev. Immunol. 2018, 18, 168–182.
- 11S. J. Patel, N. E. Sanjana, R. J. Kishton, A. Eidizadeh, S. K. Vodnala, M. Cam, J. J. Gartner, L. Jia, S. M. Steinberg, T. N. Yamamoto, A. S. Merchant, G. U. Mehta, A. Chichura, O. Shalem, E. Tran, R. Eil, M. Sukumar, E. P. Guijarro, C. P. Day, P. Robbins, S. Feldman, G. Merlino, F. Zhang, N. P. Restifo, Nature 2017, 548, 537–542.
- 12S. Jhunjhunwala, C. Hammer, L. Delamarre, Nat. Rev. Cancer 2021, 21, 298–312.
- 13I. Cebrian, G. Visentin, N. Blanchard, M. Jouve, A. Bobard, C. Moita, J. Enninga, L. F. Moita, S. Amigorena, A. Savina, Cell 2011, 147, 1355–1368.
- 14Y. Xia, Y. Xie, Z. Yu, H. Xiao, G. Jiang, X. Zhou, Y. Yang, X. Li, M. Zhao, L. Li, M. Zheng, S. Han, Z. Zong, X. Meng, H. Deng, H. Ye, Y. Fa, H. Wu, E. Oldfield, X. Hu, W. Liu, Y. Shi, Y. Zhang, Cell. 2018, 175, 1059–1073.
- 15P. J. Mullen, R. Yu, J. Longo, M. C. Archer, L. Z. Penn, Nat. Rev. Cancer 2016, 16, 718–731.
- 16T. W. Chen, F. F. Yin, Y. M. Yuan, D. X. Guan, E. Zhang, F. K. Zhang, H. Jiang, N. Ma, J. J. Wang, Q. Z. Ni, L. Qiu, J. Feng, X. L. Zhang, Y. Bao, K. Wang, S. Q. Cheng, X. F. Wang, X. Wang, J. J. Li, D. Xie, Nat. Commun. 2019, 10, 2510.
- 17S. M. El-Refai, J. D. Brown, S. M. Arnold, E. P. Black, M. Leggas, J. C. Talbert, JCO Clin. Cancer Inform. 2017, 1, 1–12.
- 18J. Jurczyluk, M. A. Munoz, O. P. Skinner, R. C. Chai, N. Ali, U. Palendira, J. M. Quinn, A. Preston, S. G. Tangye, A. J. Brown, E. Argent, J. B. Ziegler, S. Mehr, M. J. Rogers, Immunol. Cell Biol. 2016, 94, 994–999.
- 19F. Bonnet, P. Poulizac, J. P. Joseph, Lancet 2017, 389, 1097–1098.
- 20O. P. Joffre, E. Segura, A. Savina, S. Amigorena, Nat. Rev. Immunol. 2012, 12, 557–569.
- 21A. O. Kamphorst, A. Wieland, T. Nasti, S. Yang, R. Zhang, D. L. Barber, B. T. Konieczny, C. Z. Daugherty, L. Koenig, K. Yu, G. L. Sica, A. H. Sharpe, G. J. Freeman, B. R. Blazar, L. A. Turka, T. K. Owonikoko, R. N. Pillai, S. S. Ramalingam, K. Araki, R. Ahmed, Science 2017, 355, 1423–1427.
- 22X. Sun, X. Zhou, X. Shi, O. A. Abed, X. An, Y. L. Lei, J. J. Moon, Nat. Biomed. Eng. 2024, 8, 1073–1091.
- 23M. Lv, M. Chen, R. Zhang, W. Zhang, C. Wang, Y. Zhang, X. Wei, Y. Guan, J. Liu, K. Feng, M. Jing, X. Wang, Y. C. Liu, Q. Mei, W. Han, Z. Jiang, Cell Res. 2020, 30, 966–979.
- 24C. Wang, L. Zhong, J. Xu, Q. Zhuang, F. Gong, X. Chen, H. Tao, C. Hu, F. Huang, N. Yang, J. Li, Q. Zhao, X. Sun, Y. Huo, Q. Chen, Y. Zhao, R. Peng, Z. Liu, Nat. Biomed. Eng. 2024, 8, 561–568.
- 25X. Sun, Y. Zhang, J. Li, K. S. Park, K. Han, X. Zhou, Y. Xu, J. Nam, J. Xu, X. Shi, L. Wei, Y. L. Lei, J. J. Moon, Nat. Nanotechnol. 2021, 16, 1260–1270.
- 26L. Wang-Bishop, B. R. Kimmel, V. M. Ngwa, M. Z. Madden, J. J. Baljon, D. C. Florian, A. Hanna, L. E. Pastora, T. L. Sheehy, A. J. Kwiatkowski, M. Wehbe, X. Wen, K. W. Becker, K. M. Garland, J. A. Schulman, D. Shae, D. Edwards, M. M. Wolf, R. Delapp, P. P. Christov, K. E. Beckermann, J. M. Balko, W. K. Rathmell, J. C. Rathmell, J. Chen, J. T. Wilson, Sci. Immunol. 2023, 8, eadd1153.
- 27X. Zhang, X. C. Bai, Z. J. Chen, Immunity 2020, 53, 43–53.
- 28K. Zhang, C. Qi, K. Cai, Adv. Mater. 2023, 35, e2205409.
- 29Q. Li, Z. Dong, Z. Cao, H. Lei, C. Wang, Y. Hao, L. Feng, Z. Liu, ACS Nano 2023, 17, 10496–10510.
- 30X. Ding, J. Zhang, S. Wan, X. Wang, Z. Wang, K. Pu, M. Wang, Y. Cao, L. Weng, H. Zhu, F. Peng, J. Chao, R. Pei, D. T. Leong, L. Wang, Nat. Nanotechnol. 2025, 20, S41565.
- 31S. Yao, B. Jin, Z. Liu, C. Shao, R. Zhao, X. Wang, R. Tang, Adv. Mater. 2017, 29, 1605903.
- 32H. Zhao, J. Xu, Y. Li, X. Guan, X. Han, Y. Xu, H. Zhou, R. Peng, J. Wang, Z. Liu, ACS Nano 2019, 13, 13127–13135.
- 33Y. Wang, Y. Xie, J. Luo, M. Guo, X. Hu, X. Chen, Z. Chen, X. Lu, L. Mao, K. Zhang, L. Wei, Y. Ma, R. Wang, J. Zhou, C. He, Y. Zhang, Y. Zhang, S. Chen, L. Shen, Y. Chen, N. Qiu, Y. Liu, Y. Cui, G. Liao, Y. Liu, C. Chen, Nano Today 2021, 38, 101139.
- 34Z. Deng, M. Xi, C. Zhang, X. Wu, Q. Li, C. Wang, H. Fang, G. Sun, Y. Zhang, G. Yang, Z. Liu, ACS Nano 2023, 17, 4495–4506.
- 35S. T. Reddy, A. J. van der Vlies, E. Simeoni, V. Angeli, G. J. Randolph, C. P. O'Neil, L. K. Lee, M. A. Swartz, J. A. Hubbell, Nat. Biotechnol. 2007, 25, 1159–1164.
- 36G. Zhu, G. M. Lynn, O. Jacobson, K. Chen, Y. Liu, H. Zhang, Y. Ma, F. Zhang, R. Tian, Q. Ni, S. Cheng, Z. Wang, N. Lu, B. C. Yung, Z. Wang, L. Lang, X. Fu, A. Jin, I. D. Weiss, H. Vishwasrao, G. Niu, H. Shroff, D. M. Klinman, R. A. Seder, X. Chen, Nat. Commun. 2017, 8, 1954.
- 37Y. Peng, C. Ye, R. Yan, Y. Lei, D. Ye, H. Hong, T. Cai, ACS Appl. Mater. Interfaces 2019, 11, 46637–46644.
- 38F. Jia, W. Huang, Y. Yin, Y. Jiang, Q. Yang, H. Huang, G. Nie, H. Wang, Adv. Funct. Mater. 2022, 33, 2204636.
- 39L. Zitvogel, L. Galluzzi, O. Kepp, M. J. Smyth, G. Kroemer, Nat. Rev. Immunol. 2015, 15, 405–414.
- 40R. Zhang, C. Wang, Y. Guan, X. Wei, M. Sha, M. Yi, M. Jing, M. Lv, W. Guo, J. Xu, Y. Wan, X. M. Jia, Z. Jiang, Cell Mol. Immunol. 2021, 18, 1222–1234.
- 41C. Liu, X. Liu, X. Xiang, X. Pang, S. Chen, Y. Zhang, E. Ren, L. Zhang, X. Liu, P. Lv, X. Wang, W. Luo, N. Xia, X. Chen, G. Liu, Nat. Nanotechnol. 2022, 17, 531–540.
- 42P. C. Tumeh, C. L. Harview, J. H. Yearley, I. P. Shintaku, E. J. Taylor, L. Robert, B. Chmielowski, M. Spasic, G. Henry, V. Ciobanu, A. N. West, M. Carmona, C. Kivork, E. Seja, G. Cherry, A. J. Gutierrez, T. R. Grogan, C. Mateus, G. Tomasic, J. A. Glaspy, R. O. Emerson, H. Robins, R. H. Pierce, D. A. Elashoff, C. Robert, A. Ribas, Nature 2014, 515, 568–571.
- 43E. Hui, J. Cheung, J. Zhu, X. Su, M. J. Taylor, H. A. Wallweber, D. K. Sasmal, J. Huang, J. M. Kim, I. Mellman, R. D. Vale, Science 2017, 355, 1428–1433.
- 44S. M. Lewis, A. Williams, S. C. Eisenbarth, Sci. Immunol. 2019, 4, eaau6085.
- 45S. Wang, D. Z. Ni, H. Yue, N. N. Luo, X. B. Xi, Y. G. Wang, M. Shi, W. Wei, G. H. Ma, Small 2018, 14, e1704272.
- 46G. Chong, R. Su, J. Gu, Y. Yang, T. Zhang, J. Zang, Y. Zhao, X. Zheng, Y. Liu, S. Ruan, R. He, W. Yin, Y. Li, H. Dong, Y. Li, Chem. Eng. J. 2022, 435, 134993.
- 47P. Bousso, Nat. Rev. Immunol. 2008, 8, 675–684.
- 48X. Sun, X. Huang, K. S. Park, X. Zhou, A. A. Kennedy, C. D. Pretto, Q. Wu, Z. Wan, Y. Xu, W. Gong, J. Z. Sexton, A. W. Tai, Y. L. Lei, J. J. Moon, ACS Nano 2024, 18, 10439–10453.
- 49Y. Sheng, Z. Li, X. Lin, L. Wang, H. Zhu, Z. Su, S. Zhang, J. Control. Release 2024, 368, 275–289.